Under the terms of the agreement, Harvard has granted Millennium a license to certain invention from the laboratory of Wade Harper and the two institutions will jointly advance the program in this novel area of research over several years under a sponsored research agreement. Research has shown various pathways that regulate cellular protein homeostasis are linked to the pathologic properties of a broad range of cancers. The initial research-based agreement is focused on advancing knowledge in this evolving field over the course of three years.
Joe Bolen, chief scientific officer of Millennium, said: “Our mutual interest in advancing this promising area of research will provide the opportunity to apply our combined knowledge and expertise and may ultimately lead to a new generation of therapies for patients.”